drugset / Trial / NCT00646763

A Randomized Study of the Site for Growth Factor Injection for Patients Undergoing Autologous Stem Cell Transplantation

NCT00646763 ↗

Phase 2 Terminated 35 enrolled Emory University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether or not the injection site of cytokines, or growth factors, has an effect on peripheral blood stem cell collection.

Timeline

Start
2008-04
Primary completion
2009-09
Completion
2011-02

Outcome

Outcome not reported

Stopped (Enrollment): “Accrual goal met”

Drugs

EvaluationDrugModalityDoseRoute
Comparator G-CSF Protein / enzyme biologic — Subcutaneous
Comparator GM-CSF Protein / enzyme biologic — Subcutaneous

Indications

No indication recorded.